Market Place
Sourcing Support
SEQENS Unit Joins Smart Immune for Clinical Batch Making
03 Dec 2024 //
PRESS RELEASE
Arkema Grants an Exclusive Technology License to SEQENS to manufacture PEKK
25 Jun 2024 //
PRESS RELEASE
Biophytis Announces Successful Industrial Transfer Of BIO101 Production To Seqens
12 Jun 2024 //
PRESS RELEASE
Pierre Luzeau, Seqens CEO Joins 73 Leaders For European Industrial Deal
21 Feb 2024 //
PRESS RELEASE
Seqens & KK India announce new partnership for lubricant additives
19 Feb 2024 //
PRESS RELEASE
Skinification: plant polysaccharides rescue damaged hair
14 Feb 2024 //
PRESS RELEASE
Seqens partners with Pleryon to develop and manufacture an innovative GMP Polymer to treat osteoarthritis
18 Jan 2024 //
PRESS RELEASE
Biophytis And Skyepharma Sign A Partnership Agreement For Bio101
25 Sep 2023 //
PRESS RELEASE
Biophytis and Seqens Sign a Partnership to Produce Sarconeos Active Compound
18 Jul 2023 //
PRESS RELEASE
Seqens enhances its manufacturing capacities in pharma polymers & lipids at Aramon’s Plant, in France.
22 Jun 2023 //
PRESS RELEASE
Explosion reported at Seqens API MFG plant in Massachusetts, causing one death
06 May 2023 //
ENDPTS
Seqens Group Expands CDMO Offerings to Include CRDO
14 Apr 2023 //
CPHI ONLINE
New investments in China
06 Apr 2023 //
PRESS RELEASE
Seqens group at DCAT Week 2023
24 Mar 2023 //
PRESS RELEASE
Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston
31 Jan 2023 //
PRESS RELEASE
Seqens chooses to reshore paracetamol production in France
16 Jan 2023 //
PRESS RELEASE
SEQENS Turku Plant (Finland) reaches 100% Renewable Energy and zero direct carbon emissions
05 Sep 2022 //
PRESS RELEASE
SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory
21 Mar 2022 //
BUSINESSWIRE
Meeting with Virginie Tarlet for the International Women’s Day
09 Mar 2022 //
PRESS RELEASE
Meeting with Yael Gofni for the International Women’s Day
08 Mar 2022 //
PRESS RELEASE
Meeting with Aïna Queiroz for the International Women’s Day
08 Mar 2022 //
PRESS RELEASE
White & Case Advises Banks on €830 Million Financing for Acquisition
23 Feb 2022 //
WHITECASE
Update on isopropanol plant expansion
25 Jan 2022 //
PRESS RELEASE
Change in SEQENS’ shareholding structure
17 Dec 2021 //
PRESS RELEASE
SK Capital becomes the new majority shareholder of Seqens – Q&A
17 Dec 2021 //
PRESS RELEASE
SK Capital Partners completes acquisition of SEQENS and merges Wavelength Pharma
17 Dec 2021 //
PRESS RELEASE
PCAS: Change of shareholders at Seqens - Appointment of a new CEO
16 Dec 2021 //
GLOBENEWSWIRE
Seqens becomes a partner of the RoLA-FLEX project
16 Dec 2021 //
PRESS RELEASE
Formic Acid Recovery for ChemoxyCare range
15 Dec 2021 //
PRESS RELEASE
Seqens Prize of the French Académie des Sciences 2021
24 Nov 2021 //
PRESS RELEASE
Raw materials, energy and transport: rising prices & availability
06 Oct 2021 //
PRESS RELEASE
Seqens Appoints Bob Huang Managing Director of North American CDMO Operations
14 Sep 2021 //
BUSINESSWIRE
SEQENS unveils its new pharmaceutical quality control laboratory
07 Sep 2021 //
PRESS RELEASE
Sodium carbonate and sodium silicate: essential ingredients in water treatment
02 Sep 2021 //
PRESS RELEASE
Virpax Inks MMS019 Manufacturing and Supply Agreement
31 Aug 2021 //
CONTRACT PHARMA
Eurazeo announces that exclusive discussions to sell its stake in SEQENS
26 Aug 2021 //
PRESS RELEASE
SK Capital Partners to acquire SEQENS and merge Wavelength Pharma
26 Aug 2021 //
PRESS RELEASE
SEQENS products: essential ingredients for better water
17 Aug 2021 //
PRESS RELEASE
Scientific Council : Seqens new solid state capabilities and services
06 Jul 2021 //
PRESS RELEASE
Labcom HitCat Inauguration in partnership with the CNRS
05 Jul 2021 //
PRESS RELEASE
France Relance program: SEQENS new paracetamol production unit
29 Jun 2021 //
PRESS RELEASE
White Paper on Aspirin: 1st result of the technology cooperation
15 Jun 2021 //
PRESS RELEASE
Professor Patrick Couvreur joins the Seqens Scientific Council
14 Jun 2021 //
PRESS RELEASE
Raymond Sinnah’s interview in 2021 Singapore Chemicals edition
07 Jun 2021 //
PRESS RELEASE
3rd Franco-German Technology Dialogue
01 Jun 2021 //
PRESS RELEASE
Seqens is proud to announce the official partnership b/W Alganelle & Sederma
20 May 2021 //
PRESS RELEASE
Essential molecules’ production in France: our investment plan
10 May 2021 //
PRESS RELEASE
Seqens’ commitment to reducing its carbon footprint
07 May 2021 //
PRESS RELEASE
Nitrosamines: quick mobilization of a multidisciplinary team in response
27 Apr 2021 //
PRESS RELEASE
Analysis of hand sanitizers: SEQENS Bourgoin-Jallieu’s Quality Control Lab
09 Mar 2021 //
PRESS RELEASE
New collaboration between SEQENS and RONDOL
08 Mar 2021 //
PRESS RELEASE
SEQENS and Rondol Group: a new collaboration in formulation research
05 Mar 2021 //
PRESS RELEASE
Meeting with Pirjo LUOMA-TOKOI for the International Day of Women Science
11 Feb 2021 //
PRESS RELEASE
French API maker Seqens primed for sale to the tune of $2.4B: report
11 Feb 2021 //
FIERCE PHARMA
Seqens majority owner looking to sell API maker amid record-high valuations
09 Feb 2021 //
ENDPTS
Decarbonization: SEQENS becomes a reference for the industry
25 Nov 2020 //
PRESS RELEASE
Essential molecules: SEQENS invests in new technologies
19 Nov 2020 //
PRESS RELEASE
A new 45,000 tons ISOPROPANOL production facility
19 Nov 2020 //
PRESS RELEASE
Seqens Opens New HPAPI Unit
07 Sep 2020 //
CONTRACTPHARMA
Seqens CDMO to enhance flow chemistry capabilities at its Seqens`Lab R&D
04 Jun 2020 //
GLOBENEWSWIRE
